Updates are available Correction dated 2020-09-24
Click to view Correction: https://doi.org/10.1007/s00417-020-04951-x
-
Authors
Widder, Randolf A. https://orcid.org/0000-0001-7487-1501
Lappas, Alexandra
Rennings, Corinna
Hild, Matthias
Roessler, Gernot F.
Dietlein, Thomas S.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 13 June 2020
Revised: 4 August 2020
Accepted: 11 August 2020
First Online: 20 August 2020
Change Date: 24 September 2020
Change Type: Correction
Change Details: The published online version contains mistake as the author's first name and last name have been interchanged as "Hild Matthias" instead of "Matthias Hild".
Compliance with ethical standards
:
: Randolf A. Widder, Alexandra Lappas, Corinna Rennings, Matthias Hild, Gernot Roessler: No financial disclosures.Thomas S. Dietlein: Consulting and lectures: Santen Pharmaceutical Osaka, Japan; Alcon Fort Worth, USA. Stock interest: Bayer Leverkusen, Germany; Johnson & Johnson New Brunswick, New Jersey. Lectures: Thea Pharma Schaffhausen, Switzerland; iStar Medical Wavre, Belgium; MeyeTech Alsdorf, Germany.
: The study and data accumulation were carried out with the approval of the Institutional Review Board (KK-0180, Ethik und Kommission Klinische Studien, Dernbacher Gruppe Katharina Kasper, Germany). The study was in adherence to the tenets of the Declaration of Helsinki and informed consent was obtained from all patients.
